Zobrazeno 1 - 10
of 14
pro vyhledávání: '"Emin Gökhan Kandemir"'
Autor:
Levent Emirzeoglu, Tolga Tuncel, Orhan Türken, Mustafa Gültepe, Serkan Celik, Bülent Karagöz, Alpaslan Özgün, Emin Gökhan Kandemir, Tuba Muftuoglu, Oğuz Biylgi
Publikováno v:
Central European Journal of Immunology. 3:338-344
Aim of the study: To investigate the percentage of CD4+CD25 high cells (including Treg cells) and CD8+CD28– cells in breast cancer patients with and without high levels of autoimmune thyroid antibodies. Material and methods: Thirty-five women with
Autor:
Levent Emirzeoglu, Oğuz Bilgi, Bülent Karagöz, Emin Gökhan Kandemir, Aptullah Haholu, Alpaslan Özgün, Tolga Tuncel
Publikováno v:
Asian Pacific Journal of Cancer Prevention. 14:7681-7684
Background: Human leukocyte antigen (HLA)-G-positive gastric cancers are associated with poor survival, but links with tumor escape mechanisms remain to be determined. Materials and Methods: We used immunohistochemistry to investigate HLA-G expressio
Autor:
Bülent Karagöz, Alpaslan Özgün, Orhan Türken, Ahmet Öztürk, Ahmet Alacacioglu, Özkan Sayan, Bahattin Yilmaz, Emin Gökhan Kandemir, Alev Akyol Erikçi, Oğuz Bilgi
Publikováno v:
Open Medicine, Vol 5, Iss 4, Pp 431-436 (2010)
To investigate CD4+CRTH2+ cells in peripheral blood in advanced stage non small cell lung cancer (NSCLC) patients. Forty-six patients with advanced stage NSCLC, who are chemotherapy or radiotherapy naïve, and 17 healthy volunteers, were enrolled in
Autor:
Bülent Karagöz, Özkan Sayan, Ergun Yucel, Alev Akyol Erikçi, Alpaslan Özgün, Ahmet Alacacioglu, Tolga Tuncel, Oğuz Bilgi, Ali İlker Filiz, Emin Gökhan Kandemir, İlker Sücüllü
Publikováno v:
Open Medicine, Vol 5, Iss 3, Pp 365-368 (2010)
The interaction between cancer cells and platelets has been known for a long time. Although platelet indices have been also investigated in several clinical settings, it has not been exactly demonstrated in cancer patients. We investigated platelet i
Autor:
Ahmet Alacacioglu, Alev Akyol Erikçi, Oğuz Bilgi, Emin Gökhan Kandemir, Özkan Sayan, Alpaslan Özgün, Bülent Karagöz
Publikováno v:
Medical Oncology. 27:199-202
Aim To investigate differences of platelet indices in breast cancer patients after tamoxifen (tmx) and anastrazole adjuvant treatment. Methods In this retrospective study, 46 postmenopausal women (20 with tmx and 26 with anastrazole) with breast canc
Autor:
Bülent Karagöz, Özkan Sayan, Alpaslan Özgün, Alev Akyol Erikçi, Emin Gökhan Kandemir, Oğuz Bilgi, Zafer Kucukodaci
Publikováno v:
Disease and Molecular Medicine, Vol 1, Iss 4, Pp 87-89 (2013)
Although ionizing radiation is strongest factor linked to multiple myeloma, increased myeloma risk has not been fully explained after pelvic radiation. Pleural involvement of MM is also rare. We present a MM case with pleural involvement as an unusua
Autor:
Bülent Karagöz, Alev Akyol Erikçi, Emin Gökhan Kandemir, Özkan Sayan, Zafer Küçükkodaci, Ahmet Ozturk, Ozlem Karabudak, Orhan Türken, Oğuz Bilgi
Publikováno v:
Electronic Journal of General Medicine. 6:136-138
Epidermodysplasia verruciformis is a rare, multifactorial disorder. The disease has genetic and immunologic components. Many patients have impaired cell-mediated immunity. Although squamous cell cancers may develop in EV patients, the association wit
Autor:
Emin Gökhan Kandemir, Bülent Karagöz, Oğuz Bilgi, Huseyin Baloglu, Alpaslan Ozgun, Tolga Tuncel
Publikováno v:
Onkologie. 36(3)
Objective: The recently discovered microRNAs (miRNAs) are non-protein-coding, endogenous small RNAs. The aim of this study was to investigate the relationship between microRNA-21 (miR-21) and the clinicopathological features of breast cancer. Materia
Autor:
Alpaslan Özgün, Melih Ünal, Ali Ayata, Emin Gökhan Kandemir, Orhan Türken, Bülent Karagöz, Oğuz Bilgi, Gunalp Uzun
Publikováno v:
Onkologie. 32(7)
Background: Anastrozole, an aromatase inhibitor, is commonly used in the adjuvant treatment of breast cancer. Anastrozole treatment is associated with a risk of thromboembolic events and retinal vascular side effects. Herein, we present a case of hem
Autor:
Bülent Karagöz, Emin Gökhan Kandemir, Mustafa Yaylaci, Özkan Sayan, Ahmet Öztürk, Orhan Türken, Alev Akyol Erikçi, Oğuz Bilgi, Mahmut Gumus
Publikováno v:
Medical oncology (Northwood, London, England). 27(1)
Aim To evaluate the CD8+CD28− and CD4+CD25+ regulatory T (Treg) cells in addition to other some lymphocyte subgroups in peripheral blood of advanced stage lung cancer patients. Methods The study group (n = 28) comprised chemotherapy and radiotherap